Fact Sheets (3)

Head Lice

Pityriasis Versicolor


Guidelines (6)
Drug Sections (22)

Dermatology in the News

NICE approves apremilast for refractory psoriasis

NICE approves apremilast for refractory psoriasis

In new guidance NICE recommends the use of apremilast (Otezla) for certain patients with chronic plaque psoriasis unresponsive to other systemic therapies.

Start brimonidine gel at low dose in rosacea, cautions MHRA

Start brimonidine gel at low dose in rosacea, cautions MHRA

Treatment with the topical rosacea treatment brimonidine (Mirvaso) should be started at a low dose and increased gradually to reduce the risk of exacerbating the condition, the MHRA has advised.

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.